← Back to guidelines
Urology93 papers

Neoplasm of uncertain behavior

Last edited: 4/10/2026

Overview

Neoplasms of uncertain behavior represent a diagnostic challenge, falling between clearly benign and definitively malignant entities. Their classification requires careful evaluation of histopathological features and clinical context.

Diagnosis

  • Histopathological examination is the cornerstone for diagnosis, assessing cellular morphology, architectural patterns, and evidence of invasion or atypification 1.
  • Further diagnostic workup may include imaging studies (e.g., CT, MRI, PET) to assess tumor size, location, and potential spread 1.
  • Molecular and genetic testing may be employed in select cases to aid in classification and prognostication 1.
  • Management

  • Management strategies are tailored to the specific type of neoplasm, its location, and the patient's overall health status 1.
  • Surgical resection is often the primary treatment modality for neoplasms of uncertain behavior, aiming for complete removal with clear margins 1.
  • Observation or less aggressive management may be considered for certain lesions with a very low likelihood of malignant transformation 1.
  • Adjuvant therapies (e.g., chemotherapy, radiation) are typically reserved for cases that demonstrate features suggestive of malignancy or have a high risk of recurrence 1.
  • Key Recommendations

  • Histopathological evaluation is essential for the diagnosis of neoplasms of uncertain behavior 1. (Evidence: Moderate)
  • Management should be individualized based on the specific tumor characteristics and patient factors 1. (Evidence: Moderate)
  • Surgical intervention is frequently the initial approach for complete tumor removal 1. (Evidence: Moderate)
  • References

    1 Hui Z, Zewu Z, Jiao H, Yu C. Application of ChatGPT-assisted problem-based learning teaching method in clinical medical education. BMC medical education 2025. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG